Aim: To determine the epidemiological, clinical, paraclinical characteristics and assess the result of surgical treatment of benign prostatic hyperplasia (BPH) in the urological department. Patients and Method: It is a retrospective descriptive study of 757 patient samples whose BPH diagnosis was pronounced and have benefited of the open surgery in urology department from January 2006 to December 2010. The variables studied were sociodemographical, clinical, paraclinical, therapeutical and the follow up. Those variables were: arterial tension, sonography, consultation reasons and hospitalization, the data provided rectal touch, the comorbidity, the prostatic specific antigen (PSA), other blood tests, urinary tests, medical management surgical treatment, the causes of death and the complications. Results: during the study period, 2406 patients were hospitalized, from them 1472 (61.18%) for low urinary tract diseases where 757 for BPH. The mean age was 64.18 years. The acute urine retention was the main cause of hospitalizations and consultations (51.51%). The rectal touch Helped in diagnosing 96.43% of cases. PSA in 74.10%, the sonography evaluated the volume of the prostate and the complications on the upper urinary tract, kidney dilatation and stones. An urgent evacuation of acute retention of urine in the bladder was done in 74.10%, a medical treatment was done in 33.47%. The open surgery was done in 66.47%. The evolution was good for 703 (92.86%), 54 died (7.14%) and the causes were various (anemia, hyperglycemia, HIV…). Conclusion: The BHP was the first reason of consultation and hospitalization in urology department in N’Djamena. Its diagnosis was done after the analysis of a beam clinical and paraclinical arguments. In the absence of an endoscopic resection column, open surgery was the only surgical treatment.
References
[1]
Fitzpatrick, J.M. (2006) The Natural History of Benign Prostatic Hyperplasia. JM Fitzpatrick. BJU Int, 97, Suppl 2, 3-6.
[2]
Lacoin, F., Fourcade, R.O., Rouprêt, M., Slama, A., Le Fur, C., Michel, E., et al. (2013) Perceptions de l’hypertrophie bénigne de la prostate par le patient et le médecin généraliste—Etude Trophée (Perceptions of Benign Prostatic Hyperplasia According to the Perspective of Patients and General Practitioners—The Trophée Study). Progrès en Urologie, 23, 50-57. https://doi.org/10.1016/j.purol.2012.10.003
[3]
Jacobsen, S.J., Girman, C.J. and Lieber, M.M. (2001) Natural History of Benign Prostatic Hyperplasia. Urology, 58, 5-16.
https://doi.org/10.1016/S0090-4295(01)01298-5
[4]
Anderson, J.B., Roehrborn, C.G., Schalken, J.A. and Emberton, M. (2001) The Progression of Benign Prostatic Hyperplasia: Examining the Evidence and Determining the Risk. European Urology, 39, 390-399.
https://doi.org/10.1159/000052475
[5]
Emberton, M., Andriole, G.L., de la Rosette, J., Djavan, B., Hoefner, K., Navarrete, R.V., et al. (2003) Benign Prostatic Hyperplasia: A Progressive Disease of Aging Men. Urology, 61, 267-273. https://doi.org/10.1016/S0090-4295(02)02371-3
[6]
Baron, J.C. and Rousselot, F. (2004) Arguments de décision de changement de traitement dans l'hypertrophie bénigne de la prostate. Annales d’Urologie, 38, 53-56.
[7]
Botchorishvili, G., Matikainen, M.P. and Lilja, H. (2009) Early Prostate-Specific Antigen Changes and the Diagnosis and Prognosis of Prostate Cancer. Current Opinion in Urology, 19, 221-226. https://doi.org/10.1097/MOU.0b013e32832a2d10
[8]
Kambou, T., Zango, B., Ekoue, F., Traore, A.C., Bonkoungou, B., Ouattara, T. and Sano, D. (2006) Traitement chirurgical de l'hypertrophie bénigne de la prostate: Au CHU sanou souro de bobo-dioulasso (Burkina Faso) résultats à court et moyen terme—A propos de 190 cas. Médecined’Afrique Noire, 53, 605-612.
[9]
Fall, P.A., Gueye, S.M., Ndoye, A.K., Diao, D., Thiam, O.B.K., Abdallahi, M.O.C., et al. (2002) Mortalité et Morbidité précoces après adénomectomie prostatique par voie transvésicale. African Journal of Urology, 8, 20-23.
[10]
Zango, B., Kambou, T. and Sanou, A. (2002) La résection transurétrale de la prostate à l’hospital Sanou Souro de Bobo-Dioulasso: A propos de 68 cas. African Journal of Urology, 8, 1-5.
[11]
Wong, M.Y.C., Lim, Y.L. and Foo, K.T. (1994) Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia—A Local Review. Singapore Medical Journal, 35, 357-359.
[12]
Ahmed Gadam, I., Nuhu, A. and Aliyu, S. (2012) Ten-Year Experience with Open Prostatectomy in Maiduguri. ISRN Urology, 2012, Article ID: 406872.
[13]
Hill, AG. And Njoroge, P. (2002) Suprapubic Transvesical Prostatectomy in a Rural Kenyan Hospital. East African Medical Journal, 79, 65-67.
https://doi.org/10.4314/eamj.v79i2.8902
[14]
Madersbacher, S., Alivizatos, G., Nordling, J., Sanz, C.R., Emberton, M. and de la Rosette, J.J. (2004) EAU 2004 Guidelines on Assessment, Therapy and Follow-Up of Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction (BPH Guidelines). European Urology, 46, 547-554.
https://doi.org/10.1016/j.eururo.2004.07.016
[15]
Evans, C.P., Fleshner, N., Fitzpatrick, J.M. and Zlotta, A.R. (2005) An Evidence-Based Approach to Understanding the Pharmacological Class Effect in the Management of Prostatic Diseases. BJU International, 95, 743-749.
https://doi.org/10.1111/j.1464-410X.2005.05390.x
[16]
McConnell, J.D., Roehrborn, C.G., Bautista, O.M., Andriole Jr., G.L., Dixon, C.M., Kusek, J.W., et al. (2003) Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The Long-Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia. The New England Journal of Medicine, 349, 2387-2398.
https://doi.org/10.1056/NEJMoa030656
[17]
Barkin, J., Guimaraes, M., Jacobi, G., Pushkar, D., Taylor, S. and van Vierssen Trip, O.B. (2003) Alpha-Blocker Therapy Can Be Withdrawn in the Majority of Men Following Initial Combination Therapy with the Dual 5alpha-Reductase Inhibitor Dutasteride. European Urology, 44, 461-466.
https://doi.org/10.1016/S0302-2838(03)00367-1
[18]
Kpatcha, T., Tchangai, B., Tengue, K., Alassani, F., Botcho, G., Darre, T., et al. (2016) Experience with Open Prostatectomy in Lomé, Togo. Open Journal of Urology, 6, 73-79.
